Ferric Maltol (BioDeep_00000837634)
代谢物信息卡片
化学式: C18H15FeO9 (431.00654299999997)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CC1=C(C(=O)C=CO1)[O-].CC1=C(C(=O)C=CO1)[O-].CC1=C(C(=O)C=CO1)[O-].[Fe+3]
InChI: /q
描述信息
B - Blood and blood forming organs > B03 - Antianemic preparations > B03A - Iron preparations > B03AB - Iron trivalent, oral preparations
D006401 - Hematologic Agents > D006397 - Hematinics > D005290 - Ferric Compounds
同义名列表
1 个代谢物同义名
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Pablo E Pergola, Nelson P Kopyt. Oral Ferric Maltol for the Treatment of Iron-Deficiency Anemia in Patients With CKD: A Randomized Trial and Open-Label Extension.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2021 12; 78(6):846-856.e1. doi:
10.1053/j.ajkd.2021.03.020. [PMID: 34029682] - Awad Mahalhal, Alessandra Frau, Michael D Burkitt, Umer Z Ijaz, Christopher A Lamb, John C Mansfield, Stephen Lewis, D Mark Pritchard, Chris S Probert. Oral Ferric Maltol Does Not Adversely Affect the Intestinal Microbiome of Patients or Mice, But Ferrous Sulphate Does.
Nutrients.
2021 Jun; 13(7):. doi:
10.3390/nu13072269. [PMID: 34209042] - Adonice Khoury, Kaley A Pagan, Michelle Z Farland. Ferric Maltol: A New Oral Iron Formulation for the Treatment of Iron Deficiency in Adults.
The Annals of pharmacotherapy.
2021 02; 55(2):222-229. doi:
10.1177/1060028020941014. [PMID: 32633548] - Jr Fraser Cummings, Aileen Fraser, Catherine Stansfield, Ian Beales, Shaji Sebastian, Sami Hoque. Ferric maltol Real-world Effectiveness Study in Hospital practice (FRESH): clinical characteristics and outcomes of patients with inflammatory bowel disease receiving ferric maltol for iron-deficiency anaemia in the UK.
BMJ open gastroenterology.
2021 02; 8(1):. doi:
10.1136/bmjgast-2020-000530. [PMID: 33622683] - Pablo E Pergola, Steven Fishbane, Tomas Ganz. Novel Oral Iron Therapies for Iron Deficiency Anemia in Chronic Kidney Disease.
Advances in chronic kidney disease.
2019 07; 26(4):272-291. doi:
10.1053/j.ackd.2019.05.002. [PMID: 31477258] - Bernd Bokemeyer, Annette Krummenerl, Christian Maaser, Stefanie Howaldt, Michael Mroß, Nick Mallard. Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency.
European journal of drug metabolism and pharmacokinetics.
2017 Apr; 42(2):229-238. doi:
10.1007/s13318-016-0334-5. [PMID: 27101422] - M A Barrand, B A Callingham, P Dobbin, R C Hider. Dissociation of a ferric maltol complex and its subsequent metabolism during absorption across the small intestine of the rat.
British journal of pharmacology.
1991 Mar; 102(3):723-9. doi:
10.1111/j.1476-5381.1991.tb12240.x. [PMID: 1364845] - M A Barrand, B A Callingham. Evidence for regulatory control of iron uptake from ferric maltol across the small intestine of the rat.
British journal of pharmacology.
1991 Feb; 102(2):408-14. doi:
10.1111/j.1476-5381.1991.tb12187.x. [PMID: 2015422] - R K Singh, M A Barrand. Lipid peroxidation effects of a novel iron compound, ferric maltol. A comparison with ferrous sulphate.
The Journal of pharmacy and pharmacology.
1990 Apr; 42(4):276-9. doi:
10.1111/j.2042-7158.1990.tb05407.x. [PMID: 1974297] - M A Barrand, B A Callingham, R C Hider. Effects of the pyrones, maltol and ethyl maltol, on iron absorption from the rat small intestine.
The Journal of pharmacy and pharmacology.
1987 Mar; 39(3):203-11. doi:
10.1111/j.2042-7158.1987.tb06249.x. [PMID: 2883285]